REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

MILD Cure Four, S. R. O. (Slovakia)

Main Activities: Pharmacies and Drug Stores | Department Stores
Secondary Activities: Drugs and Druggists' Sundries Merchant Wholesalers | Other Publishers | Accounting, Tax Preparation, Bookkeeping, and Payroll Services | Office Administrative Services
Full name: MILD Cure Four, S. R. O. Profile Updated: July 15, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

MILD Cure Four, S. R. O. is an enterprise located in Slovakia, with the main office in Kosice. The company operates in the Pharmacies and Drug Stores sector. The enterprise was incorporated on November 01, 2012. The total number of employees is currently 10 - 19 (2025). The company’s latest financial report indicates a net sales revenue increase of 7.84% in 2024. Its’ total assets recorded a growth of 7.45%. The net profit margin of MILD Cure Four, S. R. O. decreased by 0.43% in 2024.

Headquarters
Moldavska cesta, 8/A
Kosice; Kosicky; Postal Code: 04011

Contact Details: Purchase the MILD Cure Four, S. R. O. report to view the information.

Basic Information
Total Employees:
Purchase the MILD Cure Four, S. R. O. report to view the information.
Registered Capital:
Purchase the MILD Cure Four, S. R. O. report to view the information.
Financial Auditors:
Purchase the MILD Cure Four, S. R. O. report to view the information.
Incorporation Date:
November 01, 2012
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after MILD Cure Four, S. R. O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
7.84%▲
Total operating revenue
7.82%▲
Operating profit (EBIT)
-21.15%▼
EBITDA
-15.03%▼
Net Profit (Loss) for the Period
-17.26%▼
Total assets
7.45%▲
Total equity
15.28%▲
Operating Profit Margin (ROS)
-0.64%▼
Net Profit Margin
-0.43%▼
Return on Equity (ROE)
-5.21%▼
Debt to Equity Ratio
-0.35%▼
Quick Ratio
0.1%▲
Cash Ratio
0%

Similar companies

Dr.Max 100 S.R.O.
 
Lekaren Rpt, S. R. O.
Benu Sk 77, S. R. O.
 
Lekaren Arcus, S.R.O.
Unizdrav Presov, S.R.O.
 
Z&T Pharma S.R.O.
Lekaren Sv. Anny S.R.O.
 
Medima-Sk S.R.O.
Gutta Slovakia, Spol. S R.O.
 
Dr. Max 102 S.R.O.
Dr.Max 22 S.R.O.
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo